Spots Global Cancer Trial Database for Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients
Official Title: Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients (SABLe): An Investigator Sponsored Trial
Study ID: NCT04717700
Conditions
Study Description
Brief Summary: An unrandomized phase 2 study of selinexor in combination with lenalidomide/ bortezomib and dexamethasone to newly diagnosed, transplant in-eligible symptomatic multiple myeloma patients in a multicenter international set-up within the Nordic Multiple Myeloma Study Group
Detailed Description: An unrandomized phase 2 study evaluating selinexor in combination with lenalidomide/ bortezomib and dexamethasone to newly diagnosed transplant in-eligible symptomatic multiple myeloma patients in a multicenter international set-up with in the Nordic Multiple Myeloma Study Group. The study will include 50 patients, recruited within the NMSG collaborating countries. After induction patient will be treated with continued lenalidomide-dexamethasone according to SWOG, with continuous 40mg selinexor weekly in the selinexor arm (experimental arm B).
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Aalborg University Hospital, Aalborg, , Denmark
Sydvestjysk Sygehus Esbjerg, Esbjerg, , Denmark
Regionshospitalet Gødstrup, Gødstrup, , Denmark
Odense University Hospital, Odense, , Denmark
North Estonia Medical Centre Foundation, Tallinn, , Estonia
Haukeland University Hospital, Bergen, , Norway
Førde Central Hospital, Førde, , Norway
Kristiansund Hospital, Kristiansund, , Norway
Oslo Universitets Hospital, Oslo, , Norway
Stavanger University Hospital, Stavanger, , Norway
St. Olavs University Hospital, Trondheim, , Norway
Contact Details
Name: Ida B Kristensen, MB
Affiliation: Odense University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Hanne Norseth, MD
Affiliation: Oslo University Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
